CDKN2A and head and neck cancer: This clinically important differentiation between HPV-associated and HPV-independent OPSCC is mirrored in the 8th edition of UICC/AJCC staging system for head and neck cancers, which includes p16 immunostaining as a surrogate for HPV status in oropharyngeal cancer cases [12].